Bionano Genomics, Inc. announced that it has entered into a securities purchase agreement to issue 2,250,000 shares of the company and Senior Secured Convertible Debentures at a principal amount of $20,000,000 issued at a discount of $2,000,000 on May 24, 2024. The debentures will have a coupon rate of 11% and will be convertible into common shares of the company at a conversion price of $2 per share. The debentures will be matured on May 24, 2026.

As a part of the transaction, the company paid $75,000 as placement agent fee in the transaction. The company announced that it has raised $20,000,000 from 4 investors pursuant to regulation D.